RxSight (RXST) EBT Growth (1y) (2021 - 2026)
RxSight (RXST) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 17.94% |
| 10 | RxSight | 259.94 Mn | -144.31 Mn | - | -2.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.17% |
| Mar 31, 2026 | -94.30% |
| Dec 31, 2025 | -54.35% |
| Sep 30, 2025 | -55.04% |
| Jun 30, 2025 | -93.86% |
| Mar 31, 2025 | 10.11% |
| Dec 31, 2024 | -115.04% |
| Sep 30, 2024 | 49.00% |
| Jun 30, 2024 | 56.00% |
| Mar 31, 2024 | 31.19% |
| Dec 31, 2023 | -22.97% |
| Sep 30, 2023 | 26.25% |
| Jun 30, 2023 | 17.65% |
| Mar 31, 2023 | 24.90% |
| Dec 31, 2022 | 425.10% |
| Sep 30, 2022 | -32.67% |
| Jun 30, 2022 | -24.18% |
| Mar 31, 2022 | -158.78% |
| Dec 31, 2021 | -1,130.99% |
| Sep 30, 2021 | -141.33% |